TriSalus Life Sciences (TLSI) Inventory Average (2023 - 2026)

TriSalus Life Sciences' Inventory Average history runs 4 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• On a quarterly basis, Inventory Average fell 16.5% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 16.5% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, up 8.07% from the prior year.
• Inventory Average improved to $3.4 million in Q1 2026 per TLSI's latest filing, from $3.2 million in the prior quarter.
• Across five years, Inventory Average topped out at $4.1 million in Q1 2025 and bottomed at $2.1 million in Q4 2023.
• The 4-year median for Inventory Average is $3.5 million (2025), against an average of $3.4 million.
• Across the five-year window, Inventory Average jumped 92.79% in 2024 and retreated 21.05% in 2025, its largest moves.
• Year by year, Inventory Average stood at $2.1 million in 2023, then surged by 92.79% to $4.0 million in 2024, then slipped by 21.05% to $3.2 million in 2025, then increased by 7.9% to $3.4 million in 2026.
• Per Business Quant, the three latest TLSI Inventory Average figures stand at $3.4 million (Q1 2026), $3.2 million (Q4 2025), and $3.5 million (Q3 2025).